Name: In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility (Video) | JoVE Journal
Uploaded: 2022-04-21T13:50:00.000+00:00
Duration: 7 min 35 s
Description: Learn quantitative retinal imaging analysis using fluorescein angiography and optical coherence tomography in a mouse model. These methods enable reliable comparison of vascular injury markers and treatment efficacy in retinal vein occlusion research.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This work was supported by the National Science Foundation Graduate Research Fellowship Program (NSF-GRFP) grant DGE - 1644869(to CKCO), the National Eye Institute (NEI) 5T32EY013933 (to AMP), the National Institute of Neurological Disorders and Stroke (RO1 NS081333, R03 NS099920 to CMT), and the Department of Defense Army/Air Force (DURIP to CMT).

This protocol follows the Association for Research in Vision and Ophthalmology (ARVO) statement for the use of animals in ophthalmic and vision research. Rodent experiments were approved and monitored by the Institutional Animal Care and Use Committee (IACUC) of Columbia University.
NOTE: Imaging was done on 2 month old C57BL/6J male mice that weighed approximately 23 g.
1. Preparation of reagents for retinal imaging
<ol>
	<li>Preparation of injectable fluorescein solution. 
	NOTE: Fluorescein is very light-sensitive. Protect from light and use it shortly after preparation.
	<ol>
		<li>Dilute fluorescein to a concentration of 1% in sterile saline.</li>
	</ol>
	</li>
	<li>Preparation of Ketamine/Xylazine
	<ol>
		<li>Dilute Ketamine and Xylazine in sterile saline accordingly for the following concentration: Ketamine (80-100 mg/kg) and Xylazine (5-10 mg/kg).</li>
	</ol>
	</li>
	<li>Sterile saline
	<ol>
		<li>Prepare a 5 mL syringe with a 26 G needle with sterile saline.</li>
	</ol>
	</li>
</ol>
2. OCT and fluorescein imaging
<ol>
	<li>Turn the retinal imaging microscope lightbox, the OCT machine, and the heated mouse platform ON.</li>
	<li>Turn the computer ON and open the imaging program.</li>
	<li>Add one drop of phenylephrine and tropicamide to each eye.</li>
	<li>Inject 150 &#181;L of anesthesia (Ketamine (80-100 mg/kg) and Xylazine (5-10 mg/kg)) intraperitoneally (IP). Determine the depth of anesthesia by toe pinch and wait until the animal is unresponsive. Apply ophthalmic ointment or artificial tears to both the eyes.</li>
	<li>Accommodate the mouse on the platform.</li>
	<li>Adjust the height and angle of the platform until the view of the retinal fundus is clear and focused. Take a picture of the fundus.</li>
	<li>Open the imaging and OCT software. In the OCT program, adjust nudge to 5.</li>
	<li>Take an OCT image at 75 &#181;m distal from the burn. Repeat for the other three quadrants of the retina.</li>
	<li>Inject 100 &#181;L of 1% fluorescein IP.</li>
	<li>Switch the camera to a 488 nm filter. Increase the camera gain to 5.</li>
	<li>Take a picture of the fundus at exactly 5 min after fluorescein injection. 
	&#8203;NOTE: Avoid prolonged exposure of the eye to the camera light at maximum setting, as fluorescein can exacerbate retinal photodamage. Keep light source off until the 5 min wait time has elapsed and the mouse is ready for imaging.</li>
</ol>
3. Aftercare
<ol>
	<li>Inject 1 mL of sterile saline IP. Apply lubricant eye drops to both the eyes. Apply ophthalmic ointment or artificial tears to both the eyes.</li>
	<li>Observe the mouse as it recovers from anesthesia. Return to the cage with other animals only when fully recovered, generally after around 40 min.</li>
</ol>
4. Assessment for exclusion criteria
<ol>
	<li>Open the fundus image taken at 24 h post-procedure to assess for exclusion criteria. Exclude the eye if any of the following criteria are identified.</li>
	<li>Assess whether the image has zero occlusions
	<ol>
		<li>Evaluate the image for the number of occluded vessels. 
		NOTE: A successful occlusion usually has some purple pigmentation on or around the burn, very thin or discontinuous vessel through the burn, faint or non-existent vessel appearance outside the burn area, and retinal discoloration from hypoxia. If the entire vessel can be seen through the white burn by the laser, the vessel failed to occlude. Sometimes the vessel will appear partially obstructed, but if it looks uninterrupted outside the burn, the vessel likely didn&#39;t occlude.</li>
		<li>For ambiguous cases, use FA imaging at the same time point to evaluate occlusions. In these images, an occlusion will appear as a break in the continuity of a vessel, often with a tapering of the surrounding vessel.</li>
		<li>If zero occlusions are identified, exclude the eye from analysis, as the RVO is considered ineffective. 
		NOTE: Occlusions typically resolve by 48-72 h post-RVO, and the presence of occlusions should no longer be used as an exclusion criterion at these time points.</li>
	</ol>
	</li>
	<li>Assess the fundus and OCT images for excessive retinal detachment 
	NOTE: Subretinal fluid accumulation is common after induction of RVO, and causes separation of neural retina from RPE. Exclusionary criteria for excessive retinal detachment are defined as follows: OCT will either be completely unviewable, or some layers will appear incredibly distorted. Image quality is poor, with a loss of resolution of outer plexiform and RPE layers. The separation between the neural retina and the choroid is greater than what the OCT field of view allows. On the fundus image, the retina tone will be nearly completely white, with some purple blotching. Part of the retina may appear distorted and out of focus. This is because it has detached and is at a different focal distance than the rest of the retina.
	<ol>
		<li>If the assessment of the images from an eye determines peripheral or complete detachment of the retina, exclude the eye from the analysis.</li>
	</ol>
	</li>
	<li>Exclude images with evidence of corneal cataract 
	NOTE: A corneal cataract appears as an opaque white dot on the mouse&#39;s cornea. Cataracts typically occur due to insufficient lubrication of the eyes while the animal is anesthetized and can be largely avoided by taking care to apply eye ointment generously. Cataracts can generally be identified before imaging by inspecting the animal. Mice that have developed cataracts should be excluded from the dataset without needing to undergo the imaging process. In imaging, cataracts will obscure the retina from the camera, and the OCT will appear warped.</li>
	<li>Assess the image for excessive hemorrhage 
	&#8203;NOTE: Excessive hemorrhage can be identified as amounts of red fluid in the image, usually obscuring retinal background, vessel, and burn. These areas of red fluid will be a brighter, opaquer red than the purple splotches that are normal in successful RVO. Hemorrhages show up at the ganglion cell layer on OCT imaging and interfere with the ability to visualize other retinal layers beneath the hemorrhage.
	<ol>
		<li>If the image is determined to have an excessive hemorrhage, exclude the eye from the analysis.</li>
	</ol>
	</li>
</ol>
5. Fluorescein image processing
<ol>
	<li>Open the fluorescein image in the image processing software.</li>
	<li>Duplicate the image</li>
	<li>Using a selection tool, carefully trace the major vessels.
	<ol>
		<li>The major vessels are the thicker veins and arteries radiating out from the optic disc. Ignore any vessels branching out from these vessels.</li>
		<li>If leakage prevents the outline of the vessel from being seen near the occlusion site, trace through the leakage in the approximate location of the vessel (maintain thickness, connect the last visible point to the next visible point).</li>
	</ol>
	</li>
	<li>In the first image, delete the selection, leaving only the background. Save this masked image.</li>
	<li>Move the selection to the second image, invert the selection and delete, isolating the vessels. Save this masked image.</li>
	<li>Open the two images in ImageJ. Open the background image and measure the integrated density.</li>
	<li>Open the vessel&#39;s image, select the outline of the vessels, and then measure the mean intensity.</li>
	<li>Divide the integrated density of the background by the mean intensity of the vessels, generating the leakage ratio for the eye.</li>
	<li>Record this leakage ratio for each eye in an experimental cohort.</li>
	<li>To further control for background, normalize experimental eyes to the mean leakage ratio of uninjured control eyes. 
	&#8203;NOTE: In order to create a standardized quantification of fluorescein leakage in the FA image, this calculation uses a ratio of the background density (where the leakage will be present) with the brightness of the major vessels to create results that control for the variation in brightness from image to image and can be reliably quantified. Eyes that are undamaged have no leakage and should theoretically have ratios of zero. The ratios calculated from these undamaged control eyes, therefore, represent background noise, and this value is used to further normalize experimental values.</li>
</ol>
6. Retinal layer thickness
<ol>
	<li>Open the OCT image in the image processing software.</li>
	<li>Trace the borders of the ganglion cell layer, inner plexiform layer, inner nuclear layer, outer plexiform layer, photoreceptor layer, and RPE layer. Measure the mean thickness of each layer.</li>
	<li>Repeat for OCT images from the other three quadrants of the retina. Average the mean layer thicknesses across the four quadrants to obtain the mean thickness of each retinal layer for the eye.</li>
	<li>Repeat for each eye in the experimental cohort.</li>
</ol>
7. Disorganization of retinal inner layers (DRIL)
<ol>
	<li>Open the OCT image in ImageJ.</li>
	<li>Using the line tool, measure the distance where the upper border of the outer plexiform layer is indistinct. 
	NOTE: It is important to differentiate between DRIL and areas of poor layer visibility caused by imaging artifacts. Poor OCT image quality may invalidate an eye for DRIL analysis if sufficient image resolution is not possible. Images with DRIL will typically have other regions or retinal layers that are clearly resolved and organized, which can be a good indicator of sufficient image quality.
	<ol>
		<li>Measure horizontally from the latitude where the disorganization begins to the latitude where the upper border of the outer plexiform layer becomes visible again, if at all. Even if the outer plexiform layer shifts upward or downward vertically, measure perfectly horizontally.</li>
		<li>There may be multiple areas of disorganization separated by areas with no disorganization. Measure these individually and calculate the sum of the distances.</li>
	</ol>
	</li>
	<li>Divide the length of disorganization by the total length of the retina visible in each OCT image to obtain the ratio of disorganization for the image.</li>
	<li>Repeat the measurement and calculation for OCT images from the other three quadrants of the retina.</li>
	<li>Take the mean of the ratios of disorganization from the four OCT images. This number represents the average disorganization for the whole retina. Repeat for each eye in the experimental cohort.</li>
</ol>

<ol><li>Tong, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+burden+of+cerebrovascular+disease+in+the+united+states%5BTitle%5D)+AND+%22Preventing+Chronic+Disease%22%5BJournal%5D)">The burden of cerebrovascular disease in the united states.</a> Preventing Chronic Disease. 16, 180411(2019).</li>
<li>Nakahara, T., Mori, A., Kurauchi, Y., Sakamoto, K., Ishii, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Neurovascular+interactions+in+the+retina%3A+physiological+and+pathological+roles%5BTitle%5D)+AND+%22Journal+of+Pharmacological+Sciences%22%5BJournal%5D)">Neurovascular interactions in the retina: physiological and pathological roles.</a> Journal of Pharmacological Sciences. 123 (2), 79-84 (2013).</li>
<li>Jaulim, A., Ahmed, B., Khanam, T., Chatziralli, I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Branch+retinal+vein+occlusion%3A+epidemiology%2C+pathogenesis%2C+risk+factors%2C+clinical+features%2C+diagnosis%2C+and+complications.+An+update+of+the+literature%5BTitle%5D)+AND+%22Retina%22%5BJournal%5D)">Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature.</a> Retina. 33 (5), 901-910 (2013).</li>
<li>Ho, M., Liu, D. T. L., Lam, D. S. C., Jonas, J. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Retinal+vein+occlusions%2C+from+basics+to+the+latest+treatment%5BTitle%5D)+AND+%22Retina%22%5BJournal%5D)">Retinal vein occlusions, from basics to the latest treatment.</a> Retina. 36 (3), 432-448 (2016).</li>
<li>Zhang, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Development+of+a+new+mouse+model+of+branch+retinal+vein+occlusion+and+retinal+neovascularization%5BTitle%5D)+AND+%22Japanese+Journal+of+Ophthalmology%22%5BJournal%5D)">Development of a new mouse model of branch retinal vein occlusion and retinal neovascularization.</a> Japanese Journal of Ophthalmology. 51 (4), 251-257 (2007).</li>
<li>Ebneter, A., Agca, C., Dysli, C., Zinkernagel, M. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Investigation+of+retinal+morphology+alterations+using+spectral+domain+optical+coherence+tomography+in+a+mouse+model+of+retinal+branch+and+central+retinal+vein+occlusion%5BTitle%5D)+AND+%22PLoS+One%22%5BJournal%5D)">Investigation of retinal morphology alterations using spectral domain optical coherence tomography in a mouse model of retinal branch and central retinal vein occlusion.</a> PLoS One. 10 (3), 0119046(2015).</li>
<li>Fuma, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+pharmacological+approach+in+newly+established+retinal+vein+occlusion+model%5BTitle%5D)+AND+%22Scientific+Reports%22%5BJournal%5D)">A pharmacological approach in newly established retinal vein occlusion model.</a> Scientific Reports. 7, 43509(2017).</li>
<li>Cavallerano, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Ophthalmic+fluorescein+angiography%5BTitle%5D)+AND+%22Clinical+Optometry%22%5BJournal%5D)">Ophthalmic fluorescein angiography.</a> Clinical Optometry. 5 (1), 1-23 (1996).</li>
<li>Laatikainen, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+fluorescein+angiography+revolution%3A+a+breakthrough+with+sustained+impact%5BTitle%5D)+AND+%22Acta+Ophthalmologica+Scandinavica%22%5BJournal%5D)">The fluorescein angiography revolution: a breakthrough with sustained impact.</a> Acta Ophthalmologica Scandinavica. 82 (4), 381-392 (2004).</li>
<li>Huang, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Optical+coherence+tomography%5BTitle%5D)+AND+%22Science%22%5BJournal%5D)">Optical coherence tomography.</a> Science. 254 (5035), 1178-1181 (1991).</li>
<li>Oberwahrenbrock, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Reliability+of+intra-retinal+layer+thickness+estimates%5BTitle%5D)+AND+%22PLoS+One%22%5BJournal%5D)">Reliability of intra-retinal layer thickness estimates.</a> PLoS One. 10 (9), 0137316(2015).</li>
<li>Avrutsky, M. I., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Endothelial+activation+of+caspase-9+promotes+neurovascular+injury+in+retinal+vein+occlusion%5BTitle%5D)+AND+%22Nature+Communications%22%5BJournal%5D)">Endothelial activation of caspase-9 promotes neurovascular injury in retinal vein occlusion.</a> Nature Communications. 11 (1), 3173(2020).</li>
<li>Colón Ortiz, C., Potenski, A., Lawson, J., Smart, J., Troy, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Optimization+of+the+retinal+vein+occlusion+mouse+model+to+limit+variability%5BTitle%5D)+AND+%22Journal+of+Visualized+Experiments%3A+JoVE%22%5BJournal%5D)">Optimization of the retinal vein occlusion mouse model to limit variability.</a> Journal of Visualized Experiments: JoVE. (174), e62980(2021).</li>
<li>Schmidt-Erfurth, U., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Guidelines+for+the+management+of+retinal+vein+occlusion+by+the+European+society+of+retina+specialists+%28EURETINA%29%5BTitle%5D)+AND+%22Ophthalmologica%22%5BJournal%5D)">Guidelines for the management of retinal vein occlusion by the European society of retina specialists (EURETINA).</a> Ophthalmologica. 242 (3), 123-162 (2019).</li>
<li>Yoshimura, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Comprehensive+analysis+of+inflammatory+immune+mediators+in+vitreoretinal+diseases%5BTitle%5D)+AND+%22PLoS+One%22%5BJournal%5D)">Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.</a> PLoS One. 4 (12), 8158(2009).</li>
<li>Mezu-Ndubuisi, O. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((In+vivo+angiography+quantifies+oxygen-induced+retinopathy+vascular+recovery%5BTitle%5D)+AND+%22Optometry+and+Vision+Science%22%5BJournal%5D)">In vivo angiography quantifies oxygen-induced retinopathy vascular recovery.</a> Optometry and Vision Science. 93 (10), 1268-1279 (2016).</li>
<li>Hui, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Quantitative+spatial+and+temporal+analysis+of+fluorescein+angiography+dynamics+in+the+eye%5BTitle%5D)+AND+%22PLoS+One%22%5BJournal%5D)">Quantitative spatial and temporal analysis of fluorescein angiography dynamics in the eye.</a> PLoS One. 9 (11), 111330(2014).</li>
<li>Berry, D., Thomas, A. S., Fekrat, S., Grewal, D. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Association+of+disorganization+of+retinal+inner+layers+with+ischemic+index+and+visual+acuity+in+central+retinal+vein+occlusion%5BTitle%5D)+AND+%22Ophthalmology.+Retina%22%5BJournal%5D)">Association of disorganization of retinal inner layers with ischemic index and visual acuity in central retinal vein occlusion.</a> Ophthalmology. Retina. 2 (11), 1125-1132 (2018).</li>
<li>Nicholson, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Diagnostic+accuracy+of+disorganization+of+the+retinal+inner+layers+in+detecting+macular+capillary+non-perfusion+in+diabetic+retinopathy%5BTitle%5D)+AND+%22Clinical+%26+Experimental+Ophthalmology%22%5BJournal%5D)">Diagnostic accuracy of disorganization of the retinal inner layers in detecting macular capillary non-perfusion in diabetic retinopathy.</a> Clinical & Experimental Ophthalmology. 43 (8), 735-741 (2015).</li>
<li>Obrosova, I., Chung, S., Kador, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Diabetic+cataracts%3A+mechanisms+and+management%5BTitle%5D)+AND+%22Diabetes%2FMetabolism+Research+and+Reviews%22%5BJournal%5D)">Diabetic cataracts: mechanisms and management.</a> Diabetes/Metabolism Research and Reviews. 26 (3), 172-180 (2010).</li>
<li>Hegde, K., Henein, M., Varma, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Establishment+of+the+mouse+as+a+model+animal+for+the+study+of+diabetic+cataracts%5BTitle%5D)+AND+%22Ophthalmic+Research%22%5BJournal%5D)">Establishment of the mouse as a model animal for the study of diabetic cataracts.</a> Ophthalmic Research. 35 (1), 12-18 (2003).</li>
<li>Takahashi, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Time+course+of+collateral+vessel+formation+after+retinal+vein+occlusion+visualized+by+OCTA+and+elucidation+of+factors+in+their+formation%5BTitle%5D)+AND+%22Heliyon%22%5BJournal%5D)">Time course of collateral vessel formation after retinal vein occlusion visualized by OCTA and elucidation of factors in their formation.</a> Heliyon. 7 (1), 05902(2021).</li>
<li>Haj Najeeb, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Fluorescein+angiography+in+diabetic+macular+edema%3A+A+new+approach+to+its+etiology%5BTitle%5D)+AND+%22Investigation+Ophthalmology+%26+Visual+Science%22%5BJournal%5D)">Fluorescein angiography in diabetic macular edema: A new approach to its etiology.</a> Investigation Ophthalmology & Visual Science. 58 (10), 3986-3990 (2017).</li>
<li>Alam, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Quantitative+optical+coherence+tomography+angiography+features+for+objective+classification+and+staging+of+diabetic+retinopathy%5BTitle%5D)+AND+%22Retina%22%5BJournal%5D)">Quantitative optical coherence tomography angiography features for objective classification and staging of diabetic retinopathy.</a> Retina. 40 (2), 322-332 (2020).</li>
<li>Uddin, M., Jayagopal, A., McCollum, G., Yang, R., Penn, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((In+vivo+imaging+of+retinal+hypoxia+using+HYPOX-4-dependent+fluorescence+in+a+mouse+model+of+laser-induced+retinal+vein+occlusion+%28RVO%29%5BTitle%5D)+AND+%22Investigation+Ophthalmology+%26+Visual+Science%22%5BJournal%5D)">In vivo imaging of retinal hypoxia using HYPOX-4-dependent fluorescence in a mouse model of laser-induced retinal vein occlusion (RVO).</a> Investigation Ophthalmology & Visual Science. 58 (9), 3818-3824 (2017).</li>
<li>Qiang, W., Wei, R., Chen, Y., Chen, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Clinical+pathological+features+and+current+animal+models+of+type+3+macular+neovascularization%5BTitle%5D)+AND+%22Frontiers+in+Neuroscience%22%5BJournal%5D)">Clinical pathological features and current animal models of type 3 macular neovascularization.</a> Frontiers in Neuroscience. 15, 734860(2021).</li>
<li>Park, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Imaging+laser-induced+choroidal+neovascularization+in+the+rodent+retina+using+optical+coherence+tomography+angiography%5BTitle%5D)+AND+%22Investigation+Ophthalmology+%26+Visual+Science%22%5BJournal%5D)">Imaging laser-induced choroidal neovascularization in the rodent retina using optical coherence tomography angiography.</a> Investigation Ophthalmology & Visual Science. 57 (9), 331(2016).</li>
<li>Chen, J., Qian, H., Horai, R., Chan, C., Caspi, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Use+of+optical+coherence+tomography+and+electroretinography+to+evaluate+retinal+pathology+in+a+mouse+model+of+autoimmune+uveitis%5BTitle%5D)+AND+%22PLoS+One%22%5BJournal%5D)">Use of optical coherence tomography and electroretinography to evaluate retinal pathology in a mouse model of autoimmune uveitis.</a> PLoS One. 8 (5), 63904(2013).</li>
</ol>

The authors declare that they have no competing financial interests.

Noninvasive rodent retinal imaging presents an avenue to study pathology and develop interventions. Previous studies have developed and optimized a mouse model of RVO, limiting variability and allowing for reliable translation of common clinical pathologies in the murine retina5,7,13. Developments in ophthalmic imaging technology further allow for the use of clinical in vivo imaging techniques such as FA and OCT in expe...

Neurovascular disease is a major healthcare problem responsible for ischemic strokes, a leading cause of mortality and morbidity, and retinal vascular diseases that lead to vision loss1,2. To model neurovascular disease, we employ a mouse model of retinal vein occlusion (RVO). This model is noninvasive and utilizes similar in vivo imaging techniques to those used to examine people with retinal vascular disease in a clinical setting. The use of this model thus increases the translational potential of studies utilizing this model. As with all mouse models, it is critical to maximize reproducibility of the model.
Retinal vascular diseases are a major cause of vision loss in people under the age of 70. RVO is the second most common retinal vascular disease after diabetic retinopathy3. Clinical features characteristic of RVO include ischemic injury, retinal edema, and vision loss as a consequence of neuronal loss3,4. Mouse models of RVO using laser photocoagulation of major vessels have been developed and refined to replicate key clinical pathologies observed in human RVO5,6,7. Advancements in ophthalmic imaging also allow for replication of noninvasive diagnostic tools used in humans, namely, fluorescein angiography (FA) and optical coherence tomography (OCT)6. Fluorescein Angiography allows for the observation of leakage due to the breakdown of the blood-retinal barrier (BRB) as well as blood flow dynamics in the retina, including sites of occlusion, using the injection of fluorescein, a small fluorescent dye8,9. OCT imaging allows for the acquisition of high-resolution cross-sectional images of the retina and the study of the thickness and organization of retinal layers10. Analysis of FA images has historically been largely qualitative, which limits the potential for direct and reproducible comparison between studies. Recently, a number of methods have been developed for the quantification of layer thickness in OCT imaging, though there is currently no standardized analysis protocol and the site of OCT image acquisition varies11. In order to properly leverage these tools, standardized, quantitative, and replicable data analysis methodology are needed. In this paper, we present three such vascular readouts used to evaluate pathological damage in a mouse model of RVO-fluorescein leakage, OCT layer thickness, and disorganization of retinal layers.

<table><tbody><tr><td>AK-Fluor 10%</td><td>Akorn</td><td>NDC: 17478-253-10</td><td>light-sensitive</td></tr><tr><td>Carprofen</td><td>Rimadyl</td><td>NADA #141-199</td><td>keep at 4 &amp;deg;C</td></tr><tr><td>GenTeal</td><td>Alcon</td><td>00658 06401</td><td></td></tr><tr><td>Image J</td><td>NIH</td><td></td><td></td></tr><tr><td>InSight 2D</td><td>Phoenix Technology Group</td><td></td><td>OCT analysis software</td></tr><tr><td>Ketamine Hydrochloride</td><td>Henry Schein</td><td>NDC: 11695-0702-1</td><td></td></tr><tr><td>Phenylephrine</td><td>Akorn</td><td>NDCL174478-201-15</td><td></td></tr><tr><td>Phoenix Micron IV</td><td>Phoenix Technology Group</td><td></td><td>Retinal imaging microscope</td></tr><tr><td>Phoenix Micron Meridian Module</td><td>Phoenix Technology Group</td><td></td><td>Laser photocoagulator software</td></tr><tr><td>Phoenix Micron Optical Coherence Tomography Module</td><td>Phoenix Technology Group</td><td></td><td>OCT imaging software</td></tr><tr><td>Phoenix Micron StreamPix Module</td><td>Phoenix Technology Group</td><td></td><td>Fundus imaging and acquisition targeting</td></tr><tr><td>Photoshop</td><td>Adobe</td><td></td><td></td></tr><tr><td>Refresh</td><td>Allergan</td><td>94170</td><td></td></tr><tr><td>Tropicamide</td><td>Akorn</td><td>NDC: 174478-102-12</td><td></td></tr><tr><td>Xylazine</td><td>Akorn</td><td>NDCL 59399-110-20</td><td></td></tr></tbody></table>

in vivo vascular injury readouts in mouse retina to promote reproducibility

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Advancements in ophthalmic imaging tools offer an unprecedented level of access to researchers working with animal models of neurovascular injury. To properly leverage this greater translatability, there is a need to devise reproducible methods of drawing quantitative data from these images. Optical coherence tomography (OCT) imaging can resolve retinal histology at micrometer resolution and reveal functional differences in vascular blood flow. Here, we delineate noninvasive vascular readouts that we use to characterize pathological damage post vascular insult in an optimized mouse model of retinal vein occlusion (RVO). These readouts include live imaging analysis of retinal morphology, disorganization of retinal inner layers (DRIL) measure of capillary ischemia, and fluorescein angiography measures of retinal edema and vascular density. These techniques correspond directly to those used to examine patients with retinal disease in the clinic. Standardizing these methods enables direct and reproducible comparison of animal models with clinical phenotypes of ophthalmic disease, increasing the translational power of vascular injury models.

These analysis methods allow for the quantification of retinal pathology captured by FA and OCT imaging. The experiments from which the representative data is extracted used C57BL/6J male mice who either served as uninjured controls or underwent the RVO procedure and received either Pen1-XBir3 treatment eyedrops or Pen1-Saline vehicle eyedrops. The RVO injury model involved the laser irradiation (532 nm) of the major veins in each eye of an anesthetized mouse following a tail-vein injection of rose bengal, a photoactivat...

Here, we present three data analysis protocols for fluorescein angiography (FA) and optical coherence tomography (OCT) images in the study of Retinal Vein Occlusion (RVO).

Advancements in ophthalmic imaging tools offer an unprecedented level of access to researchers working with animal models of neurovascular injury. To ...

in-vivo-vascular-injury-readouts-mouse-retina-to-promote

Research

JoVE Journal

Neuroscience

A method for the incorporation of plasmid DNA into murine retinal cells for the purpose of performing either gain- or loss of function studies in vivo is presented.  This method capitalizes on the transient increase in permeability of cell plasma membranes induced by the application of an external electrical field.

In vivo Electroporation of Developing Mouse Retina

Intravital microscopy can be used in animals to visualize and measure retinal vascular diameters, bloodstream velocities, and total retinal blood flow.

Intravital Video Microscopy Measurements of Retinal Blood Flow in Mice

The rodent retina has long been recognized as an accessible window to the brain. In this technical paper we provide a protocol that employs the mouse model of oxygen-induced retinopathy to study the mechanisms that lead to failure of vascular regeneration within the central nervous system after ischemic injury. The described system can also be harnessed to explore strategies to promote regrowth of functional blood vessels within the retina and CNS.

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Here, we present the usefulness of longitudinal in vivo imaging in the follow-up of morphological changes of laser-induced choroidal neovascularization in mice.

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model

Many vision-threatening ocular diseases are associated with dysfunctional retinal microvessels. Therefore, the measurement of retinal arteriole responses is important to investigate the underlying pathophysiological mechanisms. This article describes a detailed protocol for mouse retinal arteriole isolation and preparation to assess the effects of vasoactive substances on vascular diameter.

Preparation Steps for Measurement of Reactivity in Mouse Retinal Arterioles Ex Vivo

Oxygen-induced retinopathy (OIR) can be used to model ischemic retinal diseases such as retinopathy of prematurity and proliferative diabetic retinopathy and to serve as a model for proof-of-concept studies in evaluating antiangiogenic drugs for neovascular diseases. OIR induces robust and reproducible neovascularization in the retina that can be quantified.

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

In vivo imaging is a powerful tool for the study of biology in health and disease. This protocol describes transpupillary imaging of the mouse retina with a standard two-photon microscope. It also demonstrates different in vivoimaging methods to fluorescently label multiple cellular cohorts of the retina.

Transpupillary Two-Photon In Vivo Imaging of the Mouse Retina

This protocol describes a detailed method for the preparation and immunofluorescence staining of mice retinal flat mounts and analysis. The use of fluorescein fundus angiography (FFA) for mice pups and image processing are described in detail as well.

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model

Here, we describe an optimized protocol for retinal vein occlusion using rose bengal and a laser-guided retinal imaging microscope system with recommendations to maximize its reproducibility in genetically modified strains.

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

This article describes a well-established and reproducible lectin stain assay for the whole mount retinal preparations and the protocols required for the quantitative measurement of vascular parameters frequently altered in proliferative and non-proliferative retinopathies.

Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies

This protocol models retinal ischemia-reperfusion injury in a mouse eye by inducing retinal ischemia via anterior chamber cannulation and intraocular pressure elevation, followed by intraocular pressure normalization to initiate the reperfusion.

Induction of Retinal Ischemia-Reperfusion Injury in a Mouse Eye Model

Learn quantitative retinal imaging analysis using fluorescein angiography and optical coherence tomography in a mouse model. These methods enable reliable comparison of vascular injury markers and treatment efficacy in retinal vein occlusion research.

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Explore More Videos